Bayer Settles Dangerous Drug Lawsuit Over Aspirin
Bayer Corp. has raised the white flag and agreed to pay $15 million to settle a class action dangerous drug lawsuit that claimed the drugmaker deceived customers by leading them to believe their aspirin drugs received approval from the Food and Drug Administration (FDA).
The dangerous drug lawsuit stems from the sale of two combination medications - Bayer Aspirin with Heart Advantage and Bayer Women’s Low Dose Aspirin + Calcium. Both products that contain both aspirin and a supplement that consumers say were sold without FDA approval, according to Law360 (subscription required).
Under the terms of the settlement, consumers who purchased the Women’s product will receive $4 per bottle while those who purchased the Heart Advantage product will receive $6.